David S. Kozin Posted May 21, 2011 Report Posted May 21, 2011 HONOLULU -- The recently approved antipsychotic lurasidone (Latuda) is still metabolically superior to risperidone (Risperdal) at one year, though it offers just comparable compliance, researchers said here. View the full article
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now